CytomX Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CTMX Nasdaq 2830 www.cytomx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CytomX Therapeutics, Inc.

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC) - Aug 27th, 2026 6:00 am
CytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlights: Varetta M Advances Toward ... - Aug 6th, 2026 11:03 pm
CytomX Therapeutics Q2 Earnings Call Highlights - Aug 6th, 2026 7:03 pm
CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2026 5:10 pm
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update - Aug 6th, 2026 2:15 pm
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer - Aug 3rd, 2026 6:00 am
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 30th, 2026 6:00 am
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors - Jul 27th, 2026 6:00 am
CytomX Therapeutics (CTMX) Upgraded to Buy: Here's Why - Jul 8th, 2026 10:00 am
Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now? - Jun 19th, 2026 1:00 am
How The Narrative Around CytomX Therapeutics (CTMX) Is Evolving With Recent Developments - Jun 11th, 2026 11:12 am
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Expanded CytomX Partnership And Positive Lynozyfic Trial Results - Jun 5th, 2026 12:22 pm
REGN Expands Cancer Deal With CytomX for Bispecific Therapeutics - Jun 4th, 2026 11:25 am
Why Regeneron (REGN) Stock Is Trading Up Today - Jun 3rd, 2026 6:31 pm
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer - Jun 3rd, 2026 6:00 am
CytomX (CTMX) Q4 2025 Earnings Transcript - Jun 2nd, 2026 11:45 am
How The CytomX Therapeutics (CTMX) Story Is Shifting With New Colorectal Cancer Data And Risks - May 28th, 2026 7:11 am
CytomX Therapeutics to Present at Upcoming June Investor Conferences - May 21st, 2026 6:00 am